Evidence map›Paper›PMID 29468055›Full record

ReviewAntimicrobial resistance and infection control2018

Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.

Gabriel Birgand, Enrique Castro-Sánchez, Sonja Hansen, Petra Gastmeier, Jean-Christophe Lucet, Ewan Ferlie, Alison Holmes, Raheelah Ahmad

Abstract readReview
In one paragraph

Review in Antimicrobial resistance and infection control, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Intermittent hemodialysis: a review of the top antimicrobial stewardship practices to be employed.Antimicrobial stewardship & healthcare epidemiology : ASHE · 2024
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Gabriel Birgand1NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Enrique Castro-Sánchez1NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Sonja Hansen2Institute of Hygiene and Environmental Health Charité, University Medicine Berlin Hindenburgdamm, 27D-12203 Berlin, Germany.
Petra Gastmeier2Institute of Hygiene and Environmental Health Charité, University Medicine Berlin Hindenburgdamm, 27D-12203 Berlin, Germany.
Jean-Christophe Lucet3INSERM, IAME, UMR 1137, F-75018 Paris, France.
Ewan Ferlie6Department of Management, King's Business School, King's College London, 30, Aldwych, London, UK.
Alison Holmes1NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.
Raheelah Ahmad1NIHR Health Protection Research Unit in Healthcare Associated Infection and Antimicrobial Resistance at Imperial College London, Hammersmith Campus, Du Cane Road, London, W12 0NN UK.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Policy makers and governments are calling for coordination to address the crisis emerging from the ineffectiveness of current antibiotics and stagnated pipe-line of new ones - antimicrobial resistance (AMR). Wider contextual drivers and mechanisms are contributing to shifts in governance strategies in health care, but are national health system approaches aligned with strategies required to tackle antimicrobial resistance? This article provides an analysis of governance approaches within healthcare systems including: priority setting, performance monitoring and accountability for AMR prevention in three European countries: England, France and Germany. Advantages and unresolved issues from these different experiences are reported, concluding that mechanisms are needed to support partnerships between healthcare professionals and patients with democratized decision-making and accountability via collaboration. But along with this multi-stakeholder approach to governance, a balance between regulation and persuasion is needed.

Indexed as

Drug Resistance, BacterialGovernmentHealth PolicyAnti-Bacterial AgentsDelivery of Health CareEnglandEuropeFranceGermanyGovernment RegulationHealth PersonnelHumansInfection ControlAnti-Bacterial AgentsAntimicrobial resistanceEuropeGovernanceHealthcare settingsInfection control

Identifiers

PMID29468055
PMCPMC5819189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.